Skip to navigation Skip to content



Funding for MS Priorities Protected in Final Fiscal Year 2014 Budget

January 29, 2014

Over the past year, MS activists sent more than 14,000 emails and visited more than 300 congressional offices to urge them to adequately fund MS research and programs and services important to people with MS and their families in Fiscal Year (FY) 2014. In mid-January, Congress finalized and the President signed into law funding levels for FY 2014 and it’s clear that Congress listened to the voices and needs of MS activists. Congress included:

  • $29.9 billion for the National Institutes of Health (NIH), $1 billion more than under sequester;
  • $5 million for the MS Congressionally Directed Medical Research Program (CDMRP), an increase of $1.2 million from pre-sequester numbers;
  • $2.56 billion for the Food and Drug Administration (FDA), restoring industry-provided user fees;
  • $2.36 million for the Lifespan Respite Care Program;
  • $3.425 billion for the Low Income Home Energy Assistance Program(LIHEAP) program, restoring sequestration reductions; and,
  • $11.7 billion for the Social Security Administration’s (SSA) administrative budget, a $650 million increase from the previous year.

This funding will help further innovative research to stop disease progression, restore function and end MS forever. It will also aid the development and availability of drugs and devices for people with MS, support family caregivers, assist families affected by MS with energy costs and ensure timely distribution of disability benefits. The Society thanks MS activists for their continued support and activism in helping important funding in FY 14.

The President is expected to release his FY 2015 budget proposal in early March, which will jumpstart congressional action on the FY 2015 budget.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.


© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization and our Identification Number (EIN) is 13-5661935.